A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com
…
continue reading
1
How We Can Do Better As A County Hospital
41:34
41:34
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
41:34
Screening/ Drug efficacy/ Sotorasib/ Adaura and moreDoor Plenary Session
…
continue reading
1
Driver mutation lung cancer - My lecture
37:22
37:22
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
37:22
My UCSF lecture on driver mutation lung cancerDoor Plenary Session
…
continue reading
1
Post ASCO wrap up with Timothee Olivier
45:27
45:27
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
45:27
We break down the best studies from ASCODoor Plenary Session
…
continue reading
1
Critical Appraisal - My 2 hour ASCO lecture - Day 2 version
1:54:09
1:54:09
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
1:54:09
Critical Appraisal - My 2 hour ASCO lecture - Day 2 version by Plenary SessionDoor Plenary Session
…
continue reading
1
Asco Prequel - We talk about what to look for
29:34
29:34
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
29:34
What you need to know in advance of ASCODoor Plenary Session
…
continue reading
1
A SM crossover - Cifu, Prasad, Mandrola
45:22
45:22
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
45:22
Should trials have carbon footprint as an endpoint?Door Plenary Session
…
continue reading
1
When Evidence EXPIRES - My Grand Rounds Today at Mt Sinai
52:42
52:42
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
52:42
My grand rounds; Beta blockers post MISingle center vs multicenter RCTMasksBoosters and moreDoor Plenary Session
…
continue reading
1
Cifu, Mandrola, Prasad - SM crossover
41:50
41:50
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
41:50
I crossover SM podcast; Harvard med students video, Justice curriculum, Masking half the yearDoor Plenary Session
…
continue reading
1
Patient advocates funded by Pharma
26:14
26:14
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
26:14
Patient advocates, Pharma funding, and is MRD a suitable endpointDoor Plenary Session
…
continue reading
5 reasons that is a bad ideaDoor Plenary Session
…
continue reading
1
Beta Blockers After Heart Attacks Don't Work
15:33
15:33
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
15:33
Another flawed quality metric. Reviewing the NEJM paper "Beta-Blockers After Myocardial Infarction and Preserved Ejection Fraction".Door Plenary Session
…
continue reading
1
Blood based and Stool DNA colon cancer screening - Two NEJM papers
26:06
26:06
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
26:06
They are shittyDoor Plenary Session
…
continue reading
1
Keynote 564 - a flawed study
17:56
17:56
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
17:56
Another flawed study Keynote 564. Pembro in adjuvant RCCDoor Plenary Session
…
continue reading
1
CONTACT-01 Cabo/ Atezo in Prostate Cancer - An Unethical trial
24:46
24:46
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
24:46
What happens when doctors run unethical studies?Door Plenary Session
…
continue reading
1
CAR T causes MDS??? Manni, Goodman, Raj, Prasad
27:27
27:27
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
27:27
Does car T cause secondary AML?We discussDoor Plenary Session
…
continue reading
1
Timothee and Prasad talk 2023 cancer trials
44:08
44:08
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
44:08
We talk about 2023 cancer trialsDoor Plenary Session
…
continue reading
1
Aaron Goodman Prasad ASH UPDATES
52:49
52:49
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk
52:49
Goodman and I discuss ash updates.My myeloma talkhttps://www.youtube.com/watch?v=jAz84yCnfjQDoor Plenary Session
…
continue reading